Including a high degree of validation, we show that a common Chr9p21 (rs10757274, A>G) CHD-risk SNP is associated with metabolic alterations to the lysoPL/lysoPA/ATX axis in human plasma (Figures 1 through 4). This evidence concerns the gene ENPP2 and coronary artery disorder.